Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Hi there
I do not write here offently but i read almost evething.
FYI this the naming at my RBC account, since the beginning at the split i think in 2013.